Artia Global Partners »

Lyra Therapeutics shares owned by Artia Global Partners

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $27k 8.8k 3.08

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Lyra Therapeutics

Perceptive Advisors
Sabby Management
Ikarian Capital
Citadel Advisors
DRW Holdings
Geode Capital Management
Artia Global Partners
BlackRock
Tower Research Capital
Royal Bank of Canada
UBS Group
FMR
EverSource Wealth Advisors
Jones Financial Companies, L.L
SBI Securities

View all funds holding Lyra Therapeutics